Brind.

CEO Michael Metzger sold shares of Syndax Pharmaceuticals stock.

1 report, 1 independent Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

CEO Michael Metzger sold shares of Syndax Pharmaceuticals stock.

Who's involved

What this event is mainly about
Syndax PharmaceuticalsMichael Metzger

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped